# Epione® Post-Market Clinical Follow-up Study

> **NCT05529979** · — · COMPLETED · sponsor: **Quantum Surgical** · enrollment: 55 (actual)

## Conditions studied

- Cancer Abdomen

## Interventions

- **DEVICE:** EPIONE® CT-Guided Percutaneous procedures

## Key facts

- **NCT ID:** NCT05529979
- **Lead sponsor:** Quantum Surgical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-28
- **Primary completion:** 2023-02-22
- **Final completion:** 2024-04-27
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2026-01-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05529979

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05529979, "Epione® Post-Market Clinical Follow-up Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05529979. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*